Updated protocols, smart pumps help with Goal #3E anticoagulant compliance
Briefings on The Joint Commission, July 1, 2008
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on The Joint Commission.
A pending survey led one four-hospital system to take a hard look at its anticoagulation therapy policies and procedures. The fact that those facilities ranged in size from 25 to 250 beds simply made the process more complicated.
Jim Lile, BS, PharmD, clinical pharmacy supervisor at MidMichigan Health (composed of Gratiot Medical Center in Alma, MI, and MidMichigan Medical Center hospitals in Midland, Gladwin, and Clare), helped update existing protocols to make them consistent across the four different facilities. “We’re probably more on the same page than I would’ve thought, considering our 25-bed acute care hospital uses the same protocol we do, and we’ve adapted that protocol to the others,” says Lile.
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on The Joint Commission.
Comments
0 comments on “Updated protocols, smart pumps help with Goal #3E anticoagulant compliance ”
Related Products
Most Popular
- Articles
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: TPO disclosures to a business associate
- Q/A: Coding infusions to correct low potassium levels
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- The debate continues: Nurses who reported physician to the Texas Medical Board file federal appeal
- State medical board will hear unprofessional charges against OB-GYN
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- Major mobile operators to support free text alerts
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Coding infusions to correct low potassium levels
- Know criteria for coverage when podiatrists use Dermagraft® tissue substitute
- Note: Clarification of reference (non-patient) laboratory testing
- HIPAA Q&A: TPO disclosures to a business associate
- Get the facts on coding for non-biodegradeable drug delivery implants
- Facility E/M Levels, 2009 OPPS
- Do not separately report defibrillation
- Defining 'integral' for self-administered drugs is challenging
- Consider the big picture before querying physicians
- Searched
